Author:
Kadushkin A. G.,Tahanovich A. D.,Movchan L. V.,Kolesnikova T. S.,Khadasouskaya E. V.,Shman T. V.
Subject
General Chemistry,Biochemistry,General Medicine,Biophysics
Reference17 articles.
1. Adeloye, D., Agarwal, D., Barnes, P.J., et al., Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade, J. Glob. Health, 2021, vol. 11, article ID 15003.
2. Agusti, A., Fabbri, L.M., Singh, D., et al., Inhaled corticosteroids in COPD: friend or foe?, Eur. Respir. J., 2018, vol. 52, article ID 1801219.
3. Babu, K.S., Kastelik, J.A., and Morjaria, J.B., Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro–con perspective, Br. J. Clin. Pharmacol., 2014, vol. 78, pp. 282–300.
4. Yang, I.A., Clarke, M.S., Sim, E.H., et al., Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst. Rev., 2012, vol. 7, article ID CD002991.
5. Lehár, J., Krueger, A.S., Avery, W., et al., Synergistic drug combinations tend to improve therapeutically relevant selectivity, Nat. Biotechnol., 2009, vol. 27, no. 7, pp. 659–666.